Supplemental material
Acta Oncologica
Volume 61, 2022 - Issue 4
ORIGINAL ARTICLES: CLINICAL ONCOLOGY
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study
Mette T. Mouritzena Department of Oncology, Aalborg University Hospital, Aalborg, Denmark;b Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark;c Department of Clinical Medicine, Aalborg University, Aalborg, DenmarkCorrespondence[email protected]
https://orcid.org/0000-0003-2061-3536View further author information
https://orcid.org/0000-0003-2061-3536View further author information, , Andreas Carusa Department of Oncology, Aalborg University Hospital, Aalborg, Denmark;b Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark;c Department of Clinical Medicine, Aalborg University, Aalborg, Denmarkhttps://orcid.org/0000-0001-9369-8628View further author information
https://orcid.org/0000-0001-9369-8628View further author information, Morten Ladekarla Department of Oncology, Aalborg University Hospital, Aalborg, Denmark;b Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark;c Department of Clinical Medicine, Aalborg University, Aalborg, Denmarkhttps://orcid.org/0000-0002-0182-1228View further author information
https://orcid.org/0000-0002-0182-1228View further author information, , Anders W. M. Nielsene Department of Oncology, Aarhus University Hospital, Aarhus N, Denmarkhttps://orcid.org/0000-0003-2843-2879View further author information
https://orcid.org/0000-0003-2843-2879View further author information, , Jacob W. Larsenf Department of Oncology, Region Hospital West Jutland, Herning, Denmarkhttps://orcid.org/0000-0002-0844-7881View further author information
https://orcid.org/0000-0002-0844-7881View further author information, , Charlotte Kristianseng Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmarkhttps://orcid.org/0000-0002-8073-5781View further author information
https://orcid.org/0000-0002-8073-5781View further author information, , , , , , , Jens B. Sørensend Department of Oncology, Copenhagen E, Denmark;m Department of Clinical Medicine, University of Copenhagen, Copenhagen N, Denmarkhttps://orcid.org/0000-0001-7780-0178View further author information
https://orcid.org/0000-0001-7780-0178View further author information, Seppo W. Langerd Department of Oncology, Copenhagen E, Denmark;m Department of Clinical Medicine, University of Copenhagen, Copenhagen N, Denmarkhttps://orcid.org/0000-0001-9732-9192View further author information
https://orcid.org/0000-0001-9732-9192View further author information, , , , , , Martin Bøgstedp Department of Hematology, Aalborg University Hospital, Aalborg, Denmark;b Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark;c Department of Clinical Medicine, Aalborg University, Aalborg, Denmarkhttps://orcid.org/0000-0001-9192-1814View further author information
https://orcid.org/0000-0001-9192-1814View further author information, , & Birgitte Bjørnharti Department of Oncology, Odense University Hospital, Odense, Denmark;j Department of Clinical Research, University of Southern Denmark, Odense, Denmark;k Odense Patient data Explorative Network (OPEN), Odense, Denmarkhttps://orcid.org/0000-0002-1331-061XView further author information
https://orcid.org/0000-0002-1331-061XView further author information show all